Delivery Order SPE2DB22D3501-SPE2DB24FWR99
Award Date
8/19/24
Potential Completion Date
9/10/24
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialized medication. The contract has a firm fixed price of $7,438.00 and a period of performance through May 30, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,314.00, is for the supply of the medication ZOLADEX 10.8 MG IMPLANT SYRNS. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product, with a ceiling value of $5,578.50. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $17,545.60 and is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product used for various healthcare applications. The contract is a firm-fixed price, delivery order type with an ultimate completion date of April 10, 2024. This award is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $9,297.50, and a performance period ending on June 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,631.84, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS medical devices. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a...
The Defense Logistics Agency (DLA) awarded a $8,772.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4565703763 ZOLADEX 10.8 MG IMPLANT SYRNS. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a range of essential medical commodities from Amerisourcebergen to...
This federal contract award, with a ceiling value of $9,297.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product used for various treatments. The contract is a firm fixed-price delivery order, with a period of performance through May 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $21,932 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS medical devices. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,610,200 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a completion date of February 29, 2024 and a potential value of $8,772.80. No set-aside designation was used for this award. AmerisourceBergen Drug Corp serves as a prime contractor to DLA, providing a wide range of...